DE1617755A1 - Process for the production of a preparation obtained by selective breeding of lactobacteria - Google Patents
Process for the production of a preparation obtained by selective breeding of lactobacteriaInfo
- Publication number
- DE1617755A1 DE1617755A1 DE19661617755 DE1617755A DE1617755A1 DE 1617755 A1 DE1617755 A1 DE 1617755A1 DE 19661617755 DE19661617755 DE 19661617755 DE 1617755 A DE1617755 A DE 1617755A DE 1617755 A1 DE1617755 A1 DE 1617755A1
- Authority
- DE
- Germany
- Prior art keywords
- lactobacteria
- germs
- bacteria
- preparation
- milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000009394 selective breeding Methods 0.000 title claims 2
- 244000052616 bacterial pathogen Species 0.000 claims description 24
- 239000002609 medium Substances 0.000 claims description 13
- 235000013336 milk Nutrition 0.000 claims description 12
- 239000008267 milk Substances 0.000 claims description 12
- 210000004080 milk Anatomy 0.000 claims description 12
- 235000015097 nutrients Nutrition 0.000 claims description 12
- 244000052769 pathogen Species 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 230000001717 pathogenic effect Effects 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 208000037386 Typhoid Diseases 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000002689 soil Substances 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- 201000008297 typhoid fever Diseases 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 208000004232 Enteritis Diseases 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 235000020186 condensed milk Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 230000006378 damage Effects 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 230000000644 propagated effect Effects 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 description 6
- 229940068140 lactobacillus bifidus Drugs 0.000 description 6
- 229940039696 lactobacillus Drugs 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 102100029365 Piwi-like protein 2 Human genes 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 206010061393 typhus Diseases 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C13/00—Cream; Cream preparations; Making thereof
- A23C13/12—Cream preparations
- A23C13/16—Cream preparations containing, or treated with, microorganisms, enzymes, or antibiotics; Sour cream
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C15/00—Butter; Butter preparations; Making thereof
- A23C15/02—Making thereof
- A23C15/06—Treating cream or milk prior to phase inversion
- A23C15/065—Addition of a treatment with microorganisms or enzymes; Addition of cultured milk products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
- A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/005—Condensed milk; Sugared condensed milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Description
890 Kempten^^BcSrowHStatto^Ruf 2 32 91890 Kempten ^^ BcSrowHStatto ^ Ruf 2 32 91
Az. s 16 17 755.2-41 10.April 1970Az. S 16 17 755.2-41 April 10, 1970
Dr.Eberhard R e h m ----^. H/m E 3/1Dr Eberhard R e h m ---- ^. H / m E 3/1
Verfahren zur HerStellung eines durch selektive Züchtung von Laktobakterien erhaltenden Präparates*Method of making a by selective Cultivation of preparations containing lactobacteria *
Die Erfindung betrifft ein Verfahren zur Herstellung eines durch selektive Züchtung von Laktobakterien erhaltenen Präparates, die Verwmdung des Präparates zur Herstellung von Nahrungsmitteln und das Präparat selbst."The invention relates to a method for producing a obtained by selective cultivation of lactobacteria Preparation, the use of the preparation for the production of food and the preparation itself. "
Laktobakterien sind die in stoff weohselphysiologischer Hinsicht spezialisiertesten Bakterien. Aus diesem Grunde werden sie in zunehmendem Maße zum Nachweis von selbst in Mikromangen vorliegenden Aminosäuren, Vitaminen und anderen Biovitalstoffen eingesetzt. Wegen ihrer besonderen Nährbodenansprüche und schwierigen Züchtung werden z.Zt.Lactobacteria are the most physiological in terms of substance Respect most specialized bacteria. For this reason, they are increasingly being used to detect themselves in Micro-amounts of amino acids, vitamins and others present Biovital substances used. Because of their special nutrient requirements and difficult breeding,
209808/1777209808/1777
wenige, verhältnismäßig robuste Arten routinemäSig verwendet. Einer der Anfälligsten und Anspruchsvollsten unter den Laktobakterien ist Lactobacillus bifidus, der im Stuhl des brustgenährten Säuglings in Reinkultur wächst, jedoch verschwindet, sobald von Muttermilch auf Flaschen-Kuhmilch umgestellt wird· Schon bei geringfügiger Änderung der Zusammensetzung des für ihn optimalen Nährbodens stellt er sein Wachstum ein.few, relatively hardy species routinely used. One of the most susceptible and demanding of the lactobacteria is Lactobacillus bifidus, which occurs in the The stool of breast-fed infants grows in its purest form, but disappears as soon as it moves from breast milk to bottled cow's milk is changed · Even with a slight change in the composition of the optimal nutrient medium for him he stops growing.
Das erfindungsgemäße Verfahren dient der Vernichtung spezieller pathogener Bakterienkeime, insbesondere Thyphus-, Parathyphus, Enteritis-, Dysentery- oder Dyspepsie-Colibakterien. .The method according to the invention is used to destroy more specifically pathogenic bacterial germs, in particular typhoid, parathyphoid, enteritis, dysentery or dyspepsia coli bacteria. .
Das erfindungsgemäße Verfahren besteht darin, daß einem Stamm Laktobakterien pathogene Bakterienkeime der zu vernichtenden species zugesetzt werden, anschliessend eine AusImpfung auf einem Nährboden erfolgt,diesem Laktobakterienkeime entnommen und erneut auf einen, pathogene Bakterienkeime dieser species enthaltenden Nährboden überimpft werden» dieses Überimpfen mehrfach wiederholt wird und die so selektiv gezüchteten Laktobakterienkeime in einem pathogenkeimfrelen Nährboden vermehrt werden.The inventive method is that a Lactobacteria strain pathogenic bacterial germs of the species to be destroyed are added, then an inoculation takes place on a nutrient medium, this lactobacteria germ taken and again on a nutrient medium containing pathogenic bacteria from these species are inoculated »this over-vaccination is repeated several times and the lactobacteria germs that are so selectively grown be propagated in a culture medium free of pathogens.
Eine Weiterbildung des Verfahrens besteht darin, daßdLe letzte Züchtung vor der Vermehrung in dem pathogenkeim-A further development of the method is that dLe last cultivation before propagation in the pathogen germ
209808/1777209808/1777
freien Fahrboden in oder auf abgetätetepathogene Keime enthaltendem Nährboden vorgenommen wird* Sieger Verfahrensachritt dient ausschliesslich der zusätzlichen gesundheitlichen Sicherheit, wenn das Verfahren industriell angewendet wird* Wenn aufgrund der Gesetzgebung andere .MaSnahmen ausreichen, um sicherzustellen, daß dem letzteren Nährboden ausschliesslich Laktobakterienkeime in ; Reinkultur entnonmen werden - was bei Üblicher Sorgfalt in Labors unter Verwendung von Spezialsdkroskopen mit Änderung des Lichtstrahienganges undbiochemischer Kontrolle leicht möglich ist, so ist dieser weitere Verfehrensschritt erlässlich und die adaptierten Laktobakterienkeime werden, dann in der letzten Züchtung einem Nährboden entnommen« der lebende pathogene Keime enthält*free floor in or on destroyed pathogens Culture medium containing germs is made * Sieger procedural step serves exclusively the additional health safety if the process is industrial is used * If, due to the legislation, other measures are sufficient to ensure that only lactobacteria germs in the latter culture medium; Pure culture can be removed - what with the usual care in laboratories using special microscopes with changing the light beam path and biochemical control is easily possible, then this further procedural step is essential and the adapted lactobacteria germs are then taken from a culture medium in the last cultivation " which contains living pathogens *
Als Laktobakterien einerseits werden insbesondere Lactobacillus bifidus und/oder Lactobacillus acidophilus und als pathogene Keime andererseits insbesondere Typhusbakterien, Paratypitaxsbekierien sowie Teile und/oder Mischungen dieser Bakterien bzw· deren Stoffwechselprodukte ■ verwendet·- .-,.->-■ '■: :" / ■■';'- . ■ . -: - . Lactobacillus bifidus and / or Lactobacillus acidophilus in particular are used as lactobacteria on the one hand and typhoid bacteria, paratypitaxic bacteria as well as parts and / or mixtures of these bacteria or their metabolic products ■ - .-, .-> - ■ '■ : " / ■■ ';' - . ■. - : -.
Weitere vorteilhafte Merkmale bestehen darin, daß als letzter pathogenkeimfreier Nährboden eiii dickflüssiger Nährboden auf Milch- und/oder Leberbasis verwendet ifird, und daß der die letzte Laktöbakterienzüchtung entheltendeFurther advantageous features consist in the fact that the last nutrient medium free of pathogens is eiii thicker Milk- and / or liver-based nutrient medium used ifird, and that the one containing the last cultivation of lactobacilli
20198 0t/20198 0t /
pathogenkeimfreie Mhrboden durch Trocknen, Gefrieren oder Gefriertrocknen haltbar gemacht wird, um eine Verzögerung des Wachstums der Bakterien zu erreichen« soil free from pathogens by drying, freezing or freeze-drying is preserved in order to delay the growth of the bacteria «
Das erfindungsgemäße Verfahren ermöglicht, adaptierten Lactobacillus bifidus selbst in großen Mengen züchten zu können· Implantiert in Kolonien, Brei oder Aufschwemmung von oben genannten Krankheitskeimen, wird Lactobacillus bifidus in erheblichem Maße wachstumsgefördert. Hierbei vollzieht sieh, wie man in Mikro-Transpläntationsversuehen mit mikromanipulatorgeführten Glasfäden zeigen kann, eine fast vollständige Vernichtung der Krankheitskeim*Kolonie zugunsten der sie schliesslich fast ausfüllenden Lactobacillus Mf idus-Kolonie ·The inventive method enables adapted To be able to grow Lactobacillus bifidus in large quantities by yourself · Implanted in colonies, pulp or suspension of the above-mentioned pathogens, Lactobacillus bifidus is promoted to a considerable extent in terms of growth. Here see how to attempt micro-transplantation show with micromanipulator-guided glass threads can, an almost complete destruction of the germ * colony in favor of the Lactobacillus Mf idus colony that eventually almost fills them
in laufenden gleichsinnigen Passagen in Ansammlungen oben angeführter Krankheitskeime gezüchteter Lactobacillus bifidus ist, auf den Menschen oder das Tier Übertragen, in der Lage« die betreffenden Krankheitskeime auch in vivo auszuzehren und soweit zu deziminieren, daß sie durch die hervorgerufene Krankheit erlischt.Lactobacillus cultivated in continuous passages in the same direction in clusters of the above-mentioned germs bifidus is transmitted to humans or animals in able to “remove the germs in question also in vivo to exhaust them and to decimate them to such an extent that they are replaced by the caused illness disappears.
209808/1777209808/1777
Werden die so gezüchteten Lactobacillus Mfidus-Bakterien gesunden Menschen oder fieren verabfolgt, z.B. in Form eines nach dem erfindungsgeaiä8en Verfahren hergestellten Präparates, so schützen sie in gleicher ?eise als physiologische Darmbakterien ihren Wirtsorganismus gegen evtl* in denKörper gelangende, oben g^annte Krankheits·- keime. ""_■■:.. ..-■"·.. "■ /:- -v ■. - .. If the Lactobacillus Mfidus bacteria cultivated in this way are administered to healthy people or animals, for example in the form of a preparation produced according to the process according to the invention, they protect their host organism against any disease mentioned above in the same way as physiological intestinal bacteria. - germs. "" _ ■■: .. ..- ■ "· .." ■ /: - -v ■. - ..
Bei spiel TFor example T
0,1 ml Reinkultur eines aus frischem Stuhl eines brusternährten Säuglings entnommenen» in vitro in Milch gezüchteten Stammes von Lactobacillus bifidus wurde in 10 ml abgerahmte Volliöilch geiaipft. Nöten 10-stündiger Bebrütung wird 0>1 oX eines pathogenen I^rspepsieoplißtammes zügegeben und 10 Stunden weiterbebrütet. Dann erf oilgt Ausiiapfung auf Platten-Nährboden und 24-stündige Änaerob-Bebrütung mit den Mitteln der handelsüblichen bakteriologischen Arbeitsbestecke. 0.1 ml pure culture of a fresh stool from a breast-fed stool Lactobacillus bifidus strain of Lactobacillus bifidus, raised in vitro in milk, was taken from infants in 10 ml Skimmed whole milk peeled off. Need 10 hours of incubation 0> 1 oX of a pathogenic strain of spepsia is added and incubated for 10 hours. Then elimination takes place on nutrient plates and incubation for 24 hours with the means of the commercially available bacteriological work utensils.
Nach Durchmusterung der geöffneten» bebrüteten Platten unter eineia handelsüblichen SpezialmikroskopV das zwei ver schiedene Bfileuchtungsarten, nSmlich einmal schräg gegen das Objekt und zum anderen in Richtung der optischen Achse hat, wobei mit der einen Beleuchtungiart im FaJiLeuohtbildAfter screening the opened »incubated plates under a commercially available special microscope the two ver different types of lighting, namely one at an angle the object and the other in the direction of the optical axis has, with the one lighting type in the FaJiLeuohtbild
20*8087177720 * 80871777
die pathogenen Dyspepsiecoli-Kolonie blau-rot, die Bifi-the pathogenic colony of dyspepsia coli blue-red, the bifi-
en
duskolonie hingegeg/siber-grau erscheinen, können beide
Keime aufgrund dieses artcharakteristischen, unterschiedlichen Farb-Erscheinungsbildes exakt getrennt und zu Subkulturzwecken, in gleicher Welse wie oben geschildert,
weit-erverwendet werden.en
duskolonie on the other hand / silver-gray, both germs can be separated exactly due to this species-characteristic, different color appearance and can be used for subculture purposes in the same way as described above.
en ■:en ■:
Nach im Abstand von zwei Tagen sich wiederholend^ monatelang durchgeführten Symbiose-Züchtungen dieser beiden Keime in Milch mit ständigen Zwischen-Selektionen der jeweils am besten an das Pathogenkeim-Eiweis adaptierten Bifiduskeirrie, schliesst sich folgende vorletzte Subkultur an: Die Dyspepsiecolikeime werden in den oben angegebenen Mengenverhältnissen in Milch geimpft, drei Stunden bebrütet und dann durch Erhitzen von 30 Minuten bei 60° G abgetötet. Dann werden in oben angegebener Menge die Bifiduskeime eingeimpft, Der wesentliche Unterschied dieser vorletzten Subkultur gegenüber den vorherigen Züchtungen besteht also darin, dad die Bifiduskeime in ausschliesslich abgetötete Dyspepsiecolikeime enthaltender Milch gezüchtet werden und somit bedenkenlos zu prophlaktisehen oder therapeutischen Zwecken per os appliziert werden können. Die letzte Bifidus-Subkultur wird dann zur massiven Keimvermehrung auf einem absolut dyspepsiecolifreien Nährboden durchgeführt. Aus diesem Nährboden, z.B. dickflüssige Milch, wird dann z.B. durch Trocknen ein haltbares Präparat gewonnen.Repeatedly every two days for months carried out symbiosis breeding of these two germs in milk with constant intermediate selections of each best adapted to the pathogen germ protein, The following penultimate subculture follows: The dyspepsia colic germs are in the proportions given above inoculated in milk, incubated for three hours and then killed by heating for 30 minutes at 60 ° G. Then the bifidus germs are inoculated in the amount specified above, The main difference between this penultimate subculture and the previous cultivars is dad the bifidus germs are grown in milk containing exclusively killed dyspepsia colic germs and thus without hesitation to see prophlactic or therapeutic Purposes can be applied per os. The final bifid subculture is then carried out on an absolutely dyspepsia coli-free nutrient medium for the massive multiplication of germs. For this A nutrient medium, e.g. thick milk, is then e.g. Drying obtained a durable preparation.
209808/1777209808/1777
TS17755TS17755
© 1 s| £ ß 1 2© 1 s | £ ß 1 2
Bruchteile 'lines HiliillterJB -einer aus stuhl Isoli©i*t@a R^iBkultas0 ■ ^on;-lactobacillus sowie gleiches- öantism ..©laes?Fractions' lines HiliillterJB -einer aus stuhl Isoli © i * t @ a R ^ iBkultas 0 ■ ^ on; -lactobacillus as well as equal- öantism .. © laes?
Typhus oder anderenpattogenen &«!&©&. tfei^a in 5-1® sal sterile fiüch ©cl©r Köadenssail.ch ©ing@isspf% imd M:» stsr leicMeii Sätienmg (et*m pH S9) von 3?~41Ö0. bebrütet, .itean •rorden 0^1 ml MiIeM densmilch eiiigegeböö-. wnd vrieaerusi Temperatur von 3?°G » 41 ®G bis ^ur tegiim^K^sn Mili@u< Säuerung bebrätet« Maeh:stänäig sioh maefe .dies®® vre.<shen^> odes? monateleag w&®a®vh.©l®n In Symbiosezllchttmg■ b©M®r Xei» ia üolgt das ÄTyphoid or other pattogenic & «! & © &. tfei ^ a in 5-1® sal sterile fiüch © cl © r Köadenssail.ch © ing @ isspf% imd M : »stsr leicMeii sätienmg (et * m pH S 9 ) of 3? ~ 41 Ö 0. incubated, .itean • Rorden 0 ^ 1 ml MiIeM the milk eiiigeböö-. wnd vrieaerusi temperature of 3? ° G »41 ®G to ^ ur tegiim ^ K ^ sn Mili @ u <acidification roasted« Maeh : constantly sioh maefe .dies®® vre. <shen ^> odes? monthly leag w & ®a®vh. © l®n In Symbiosezllchttmg ■ b © M®r Xei »ia o follows the Ä
nMhr-boden rai'tnMhr-soil rai't
bacillus -.-bifidus ms ©iasr · ieoliertbacillus -.- bifidus ms © iasrioliert
kultur auf ©inenculture on © inen
übertragen und b®forSt@tos BiW R@iÄ@£t der' KudLtcnr. MM saittels eines handelsübliclies Sp©Eiels&IkrosfeopB lauf®nd überprüft«' Dieser letzt® Rährbode% d®r aaeeel^leesiicb Lact©bacillue- -bifidus-Keime iß tteSjBBt&i&'fe&tä^ transferred and b®forSt @ to s BiW R @ iÄ @ £ t der 'KudLtcnr. MM saittels einer Handelsübliclies Sp © Eiels & IkrosfeopB continuously checked «'This last® Rährbode% d®r aaeeel ^ leesiicb Lact © bacillue- -bifidus-Germ eats tteSjBBt & i &' fe & ta ^
FrisdtmilcSi) * giber SM^k KotodeiiEm4äc^s "Milel3pi!lverf in kleinen Mengen i ^ FrisdtmilcSi) * giber SM ^ k KotodeiiEm4äc ^ s "Milel3pi! Lver f in small quantities i ^
Eine Öse Bifidus~Reinkultur aus Säuglings-Bruststuhl wird' in eine auf Festnährboden auswachsende Kolonie von Dyspepsiecoli, Typhus o,dergl« transplantiert und, 1-2 Tage bebrütet« Danach werden beide Keime der Symblontenkolonie in Mischung auf einem bekannten geeigneten Bifidus-Festnährboden überimpft und "bebrütet". Nunmehr werden Subkulturen ständig über einen Zeitraum von mehreren Wochen wiederholte Schliesslich werden durch weit ausgezogenes Ausstreichen auf Bifidus-Festnährboden beide Keime in Einzelkolonien getrennt* Dann wird, eine, isoliert liegende Bifiduskolonie entnommen und zur massiven Keimvermehrung auf ©inen Fest- oder Flüssignährboden, insbesondere einem dickflüssigen Nährboden auf Milch« und/öder Leberbasis übertragen und bebrütet. Dieser Nährboden wird anschliessend 2.B. durch Trocknen, Gefrieren oder Gefriertrocknen haltbar gemacht und zu einem verkaufsfähigen Präparat verarbeitet.An eyelet Bifidus ~ pure culture from an infant breast chair becomes' into a colony of dyspepsia coli growing on solid culture medium, Typhus o, dergl "transplanted and incubated for 1-2 days" After that, both germs of the symbol colony are mixed together inoculated on a known suitable bifidus medium and "incubated". Subcultures are now being repeated over and over again over a period of several weeks are spread by spreading them on a solid Bifidus medium both germs separated into individual colonies * Then, an isolated bifid colony is removed and used massive germ multiplication on solid or liquid culture media, in particular transferred to a thick nutrient medium based on milk and / or liver and incubated. This breeding ground becomes then 2.B. by drying, freezing or freeze drying made durable and a salable preparation processed.
Das erfindungsgemäß hergestellte» adaptierte Laktobalcterien enthaltende Präparat wird herkömmlichen Nahrungsmitteln, insbesondere auf Milchbasis» also Kondensmilch, Milchpulver, Rahm» Joghurt, Käse und Batter zugesetzt und schützt . somit den Menschen vorbeugend gegen Erkrankung. Selbstverständlich kann das Präparat auch unmittelbar als Heilmittel verwendet werden. The "adapted lactobalceria-containing preparation produced according to the invention is added to conventional foods, in particular milk-based" ie condensed milk, milk powder, cream, yoghurt, cheese and batter and protects. thus the people preventive against illness. Of course, the preparation can also be used directly as a remedy.
209808/1777 bad original209808/1777 bad original
Claims (7)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DER0044408 | 1966-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1617755A1 true DE1617755A1 (en) | 1972-02-17 |
Family
ID=7407288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19661617755 Pending DE1617755A1 (en) | 1966-10-21 | 1966-10-21 | Process for the production of a preparation obtained by selective breeding of lactobacteria |
Country Status (12)
Country | Link |
---|---|
AT (1) | AT279805B (en) |
BE (1) | BE705396A (en) |
CH (1) | CH492785A (en) |
DE (1) | DE1617755A1 (en) |
DK (1) | DK119127B (en) |
ES (1) | ES346285A1 (en) |
FR (1) | FR1549431A (en) |
GB (1) | GB1208599A (en) |
IT (1) | IT1053673B (en) |
LU (1) | LU54704A1 (en) |
NL (1) | NL6714285A (en) |
NO (1) | NO122671B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135199A2 (en) * | 1983-09-19 | 1985-03-27 | Omron Tateisi Electronics Co. | Sealed slide switch |
US4814565A (en) * | 1983-09-19 | 1989-03-21 | Omron Tateisi Electronics Co. | Sealed slide switch |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI59925C (en) | 1980-01-11 | 1981-11-10 | Esko Viljo Nurmi | FOERFARANDE FOER FRAMSTAELLNING AV ETT BAKTERIEPREPARAT ANVAENDBART FOER FOERHINDRANDE AV SALMONELLAINFEKTION HOS FJAEDERFAE |
US4839281A (en) * | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
-
1966
- 1966-10-21 DE DE19661617755 patent/DE1617755A1/en active Pending
-
1967
- 1967-10-12 CH CH1431767A patent/CH492785A/en not_active IP Right Cessation
- 1967-10-13 AT AT927267A patent/AT279805B/en not_active IP Right Cessation
- 1967-10-16 NO NO170137A patent/NO122671B/no unknown
- 1967-10-18 GB GB47367/67A patent/GB1208599A/en not_active Expired
- 1967-10-20 ES ES346285A patent/ES346285A1/en not_active Expired
- 1967-10-20 DK DK524667AA patent/DK119127B/en unknown
- 1967-10-20 FR FR1549431D patent/FR1549431A/fr not_active Expired
- 1967-10-20 BE BE705396D patent/BE705396A/xx unknown
- 1967-10-20 NL NL6714285A patent/NL6714285A/xx unknown
- 1967-10-20 IT IT21825/67A patent/IT1053673B/en active
- 1967-10-20 LU LU54704D patent/LU54704A1/xx unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135199A2 (en) * | 1983-09-19 | 1985-03-27 | Omron Tateisi Electronics Co. | Sealed slide switch |
EP0135199A3 (en) * | 1983-09-19 | 1987-08-05 | Omron Tateisi Electronics Co. | Sealed slide switch |
US4814565A (en) * | 1983-09-19 | 1989-03-21 | Omron Tateisi Electronics Co. | Sealed slide switch |
US4833280A (en) * | 1983-09-19 | 1989-05-23 | Omron Tateisi Electronics Co. | Slide switch having improved holding structure for the movable contact |
Also Published As
Publication number | Publication date |
---|---|
GB1208599A (en) | 1970-10-14 |
CH492785A (en) | 1970-06-30 |
LU54704A1 (en) | 1968-01-26 |
DK119127B (en) | 1970-11-16 |
IT1053673B (en) | 1981-10-10 |
FR1549431A (en) | 1968-12-13 |
BE705396A (en) | 1968-03-01 |
AT279805B (en) | 1970-03-25 |
NO122671B (en) | 1971-07-26 |
ES346285A1 (en) | 1969-01-01 |
NL6714285A (en) | 1968-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60032599T2 (en) | BACTERIENSTAMM, PROCESSED PLANT EXTRACTS AND PROBIOTIC PREPARATIONS FOR HUMAN AND AUTHENTIC USE | |
DE69119110T2 (en) | New lactic acid bacteria, antibacterial compounds made from these bacteria, fermented milk starters containing these bacteria, and methods of producing fermented milk using this initiator | |
DE69214987T2 (en) | Sour milk and process for its production | |
DE2656159C2 (en) | Fermented milk product containing viable bifidobacteria and process for its preparation | |
DE60120018T2 (en) | Process for making 'vegetable yoghurt' by fruit or vegetable fermentation | |
EP0195213A2 (en) | Lactic acid containing fruit products and process for lactic fermentation of fruit products | |
DE3781652T2 (en) | PREPARATION SUITABLE FOR TREATMENT OF COLONAL DISEASES. | |
CH629533A5 (en) | METHOD FOR OBTAINING INSULIN BY MEANS OF GENETICALLY REFORMED FUNGUS CELLS. | |
CH627348A5 (en) | METHOD FOR THE PRODUCTION OF FERMENTED MILK CONTAINING VIVIDABLE BIFIDOBACTERIES AND USE OF THE MILK SO OBTAINED. | |
AT391792B (en) | METHOD FOR PRODUCING A DIETETIC AGENT FOR EFFECTIVELY INHIBITING AND FIGHTING CLOSTRIDIA | |
DE60121589T2 (en) | MICROORGANISMS INVOLVING IN THE SURFACE GLYCOLYSIS OF INTESTINAL CELLS | |
DE602005005032T2 (en) | STORABLE PRODUCT WITH LIVING MICROORGANISMS | |
DE3120505A1 (en) | METHOD FOR PRODUCING PITCH-RESISTANT SOURCE MILK PRODUCTS | |
DE60037343T2 (en) | BIFIDOBAKTERIA WITH THE ABILITY TO PREVENT DIARRHOE | |
DE1617755A1 (en) | Process for the production of a preparation obtained by selective breeding of lactobacteria | |
DE1019896B (en) | Process for the production of milk products, such as sour milk or the like, with the addition of bacteria | |
EP0344786B1 (en) | Inhibiting agent for clostridia | |
DE1692313A1 (en) | Process for making dairy products | |
DE3713136A1 (en) | Symbiotic mixt. of lactic bateria in conc. dried form - esp. contg. Lactobacillus bulgaricus and Streptococcus thermophilus, useful for making cheese, yoghurt, etc. | |
DE602004003832T2 (en) | USE OF BACILLI BACTERIA TO PREVENT SPINE COMPRESSION SYNDROME IN SALMONIDES | |
DE2725731C2 (en) | Process for the manufacture of a milk-based foodstuff | |
DE1946661A1 (en) | Use of bifidus microorganisms for growing - and fattening animals | |
DE3326347C2 (en) | Process for producing drinking whey | |
DE698833C (en) | Protective bushing for rotating shafts | |
DE3608423A1 (en) | METHOD FOR CONTROLLING STABLE MICROBIAL MIXED BIOZOENOSES |